CN113368225A - Compound prescription for treating diabetes and three highs - Google Patents

Compound prescription for treating diabetes and three highs Download PDF

Info

Publication number
CN113368225A
CN113368225A CN202110763131.5A CN202110763131A CN113368225A CN 113368225 A CN113368225 A CN 113368225A CN 202110763131 A CN202110763131 A CN 202110763131A CN 113368225 A CN113368225 A CN 113368225A
Authority
CN
China
Prior art keywords
prescription
radix
rhizoma
treating diabetes
recipe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202110763131.5A
Other languages
Chinese (zh)
Inventor
徐庆恒
淡学双
周福双
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Shuangpeng Health Technology Co ltd
Original Assignee
Sichuan Shuangpeng Health Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Shuangpeng Health Technology Co ltd filed Critical Sichuan Shuangpeng Health Technology Co ltd
Priority to CN202110763131.5A priority Critical patent/CN113368225A/en
Publication of CN113368225A publication Critical patent/CN113368225A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/233—Bupleurum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284—Atractylodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488—Pueraria (kudzu)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/894—Dioscoreaceae (Yam family)
    • A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969—Polygonatum (Solomon's seal)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9062—Alpinia, e.g. red ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)

Abstract

The invention discloses a compound prescription for treating diabetes and hypertension, hyperlipidemia and hyperglycemia, which consists of a main prescription and a supplement prescription, wherein the supplement prescription consists of earthworm protein, nattokinase, lumbrokinase, hirudin, inulin, red yeast rice, sunflower disc small molecular peptide, edible selenium powder and glutathione. The invention mainly adopts a main formula and a correction formula to realize the effective prevention and treatment of three highs by combining Chinese and western medicines, has obvious treatment effect, combines the pathogenesis and pathology of the three highs, can realize the treatment of both principal and secondary aspect of disease, and can be matched with a dietary therapy auxiliary formula and a vitamin auxiliary formula to improve the immunity of human bodies and strengthen the treatment effect.

Description

Compound prescription for treating diabetes and three highs
Technical Field
The invention relates to the technical field of medicines, in particular to a compound prescription for treating diabetes and hypertension, hyperlipidemia and hyperglycemia.
Background
Three highs refer to hyperlipidemia, hypertension and hyperglycemia, wherein serious hyperglycemia can cause diabetes. The main causes of the three high diseases are due to long-time diet problems, such as excessive lipid and excessive alcohol in the diet, and the lipid alcohol substances in the body are gradually increased because reasonable exercise is not performed to promote the metabolism of the lipid alcohol; the substances are mixed in blood to block capillary vessels, and the lipid-alcohol substances are easily combined with free mineral ions in the body to form thrombus with the lapse of time; thrombus is easy to accumulate and calcify at the corners or the bottle necks of the blood vessels; meanwhile, the thrombus is more and more, so that the diameter of the blood vessel is reduced; in order to maintain a sufficient blood supply to the heart, the blood pressure is increased, causing hypertensive diseases; it may also be caused by excessive smoking or excessive drinking, impairment of the spleen and stomach, dysfunction of the spleen in transportation, and failure of the diet to normalize.
Disclosure of Invention
Therefore, based on the above background, the present invention provides a compound formulation for treating diabetes and hypertension, which can be used for treating hyperlipidemia, hyperglycemia, hypertension, etc., has excellent therapeutic effects on insulin-dependent diabetes and non-insulin-dependent diabetes, and has excellent effects of lowering blood sugar and urine sugar, strengthening body constitution, and increasing body weight.
The technical scheme of the invention is as follows:
a compound prescription for treating diabetes and three highs consists of a main prescription and a supplement prescription, wherein the main prescription is prepared from the following raw materials:
radix astragali, rhizoma Polygonati, Coptidis rhizoma, Ginseng radix Rubri, radix scrophulariae, Saviae Miltiorrhizae radix, rhizoma Dioscoreae, pollen, radix Puerariae, fructus Alpinae Oxyphyllae, semen plantaginis, rhizoma Atractylodis, cimicifugae rhizoma, bupleuri radix, pericarpium Citri Tangerinae, Poria, Atractylodis rhizoma, and Glycyrrhrizae radix;
the prescription is prepared from the following raw materials:
earthworm protein, nattokinase, lumbrokinase, hirudin, inulin, red yeast rice, sunflower disc small molecular peptide, edible selenium powder and glutathione.
Further, the dosage of each raw material of the main formula is as follows:
120-360 g of astragalus mongholicus, 120-360 g of rhizoma polygonati, 20-60 g of coptis chinensis, 60-180 g of red ginseng, 120-360 g of radix scrophulariae, 120-360 g of salvia miltiorrhiza, 120-360 g of raw Chinese yam, 120-360 g of raw pollen, 40-120 g of radix puerariae, 20-60 g of sharpleaf galangal fruit, 10-30 g of semen plantaginis, 20-60 g of rhizoma atractylodis, 20-60 g of rhizoma cimicifugae, 20-60 g of radix bupleuri, 20-60 g of pericarpium citri reticulatae, 20-60 g of poria cocos, 20-60 g of rhizoma atractylodis macrocephalae and 10-30 g of liquorice;
further, the food therapy auxiliary formula comprises the following raw materials in parts by weight: 100 g of peanut, medlar, red date, gordon euryale seed, ginger and astragalus root respectively.
Furthermore, the vitamin auxiliary formula also comprises vitamin B group vitamins, folic acid, mercurial-preserving honeysuckle tablets and dried yeast tablets.
Furthermore, the main formula of the invention can be prepared into any conventional oral administration dosage form by adopting a conventional method of a traditional Chinese medicine preparation.
Furthermore, various conventional auxiliary materials required for preparing different dosage forms can be added into the main formula of the invention to prepare any common oral dosage form, such as: pill, powder, tablet, capsule, oral preparation, etc.
In the main part of the invention: the astragalus membranaceus is sweet in taste and warm in nature, enters lung and spleen channels, and has the effects of tonifying qi, consolidating superficial resistance, promoting urination, expelling toxin, expelling pus, healing sores, promoting granulation and the like; rhizoma polygonati is sweet in taste and neutral in nature, and has the effects of tonifying qi and yin, strengthening spleen, moistening lung, tonifying kidney and the like, and the rhizoma polygonati enters spleen channels, lung channels and kidney channels; the coptis chinensis is bitter in taste and cold in nature, and has the effects of clearing heat, drying dampness, purging fire, detoxifying and the like, and the coptis chinensis is responsible for heart, spleen, stomach, liver, gallbladder and large intestine channels; the red ginseng is sweet in taste, slightly bitter in taste and warm in nature, has the effects of invigorating primordial qi, recovering pulse, relieving depletion, benefiting qi, controlling blood and the like, and is used for invigorating spleen, lung and heart channels; radix scrophulariae is sweet and bitter in taste and slightly cold in nature, enters lung, stomach and kidney channels, and has the effects of cooling blood, nourishing yin, purging pathogenic fire, removing toxicity and the like; the salvia miltiorrhiza, which is bitter in taste and slightly cold in nature, enters heart and liver channels and has the effects of removing blood stasis, relieving pain, activating blood circulation, stimulating the menstrual flow, clearing away heart fire, relieving restlessness and the like; the Chinese yam is sweet in taste and neutral in nature, has the functions of tonifying spleen, nourishing stomach, promoting the production of body fluid, benefiting lung, tonifying kidney, arresting seminal emission and the like, and enters spleen, lung and kidney channels; the pollen is sweet, sour and cold in taste, and has the effects of clearing heat, relieving restlessness, promoting the production of body fluid, quenching thirst and the like; the kudzu vine root is sweet and pungent in taste and cool in nature, and has the effects of relieving muscles and reducing fever, promoting the production of body fluid, promoting eruption, invigorating yang, stopping diarrhea and the like, and the spleen and stomach channels are reached; fructus alpiniae oxyphyllae, pungent in taste, warm in nature, and capable of entering spleen and kidney meridians, and has the effects of warming spleen, warming kidney, strengthening qi, arresting seminal emission and the like; the plantain seed is sweet in taste and slightly cold in nature, enters liver, kidney, lung and small intestine channels, and has the effects of clearing heat, promoting urination, excreting dampness, treating stranguria, improving eyesight and the like; the rhizoma atractylodis is pungent and bitter in taste and warm in nature, enters spleen, stomach and liver channels, and has the effects of eliminating dampness, strengthening spleen, dispelling wind and cold, improving eyesight and the like; cimicifugae rhizoma, pungent and slightly sweet in taste, slightly cold in nature, enters lung, spleen, stomach and large intestine channels, and has the effects of relieving exterior syndrome, promoting eruption, clearing heat and detoxicating, and lifting yang qi; the radix bupleuri is bitter in taste and slightly cold in nature, enters liver and gallbladder channels, and has the effects of harmonizing exterior and interior, soothing liver, invigorating yang and the like; the dried orange peel is bitter and pungent in taste and warm in nature, enters lung and spleen channels, and has the effects of regulating qi, strengthening spleen, eliminating dampness and phlegm and the like; poria cocos is sweet and light in flavor, has mild nature, has effects of benefiting heart, lung, spleen and kidney channels, promoting diuresis, eliminating dampness, invigorating spleen and calming heart; the bighead atractylodes rhizome is bitter and sweet in taste and warm in nature, enters spleen and stomach channels, and has the effects of strengthening spleen and tonifying qi, eliminating dampness and promoting diuresis, arresting sweating and the like; the liquorice has sweet taste and mild nature, enters heart, lung, spleen and stomach channels, and has the effects of tonifying spleen and qi, clearing heat and detoxicating, eliminating phlegm and stopping cough, relieving spasm and pain, harmonizing the drugs and the like.
In the correction of the present invention, the correction is performed,
the Lumbricus protein has effects of improving microcirculation, dissolving fresh and old thrombi, promoting capillary vessel regeneration, softening blood vessel, reducing blood viscosity, regulating blood pressure, and reducing blood sugar, and can be used for treating hemiplegia, thrombi type diseases, cardiovascular disease and cerebrovascular disease, and also has anti-tumor effect;
nattokinase has effects of dissolving thrombus, reducing blood viscosity, improving blood circulation, softening and increasing blood vessel elasticity, and its thrombolysis speed is 19 times of that of urokinase. It has obvious effect on treating ischemic cerebral apoplexy, can inhibit platelet coagulation, and has positive effects on preventing and treating cardiovascular and cerebrovascular embolism and embolic senile dementia;
the lumbrokinase has special affinity with thrombus (fibrin), can track thrombolysis, effectively dissolve thrombus, improve microcirculation, strengthen collateral circulation of cerebral vessels, openly repair damaged endothelial cells of blood vessels, increase elasticity of blood vessels, improve oxygen supply function of blood vessels, reduce blood viscosity, reduce platelet aggregation rate, and inhibit thrombus from forming again. It can repair necrotic brain cells around after thrombosis, save half dark space, and can be used for treating diseases of heart, cerebral vessels, endocrine, respiratory system, etc.;
hirudin has anticoagulant and antithrombotic polypeptide substances, can inhibit platelet aggregation, blood cell depolymerization and thrombus dissipation, promote microcirculation, eliminate fatty liver, eliminate atherosclerosis, activate thrombolytic function of human body, and has effects of reducing blood lipid, improving hemorheology, resisting tumor, and treating multiple thrombosis diseases, and preventing apoplexy and secondary apoplexy.
Inulin has effects of controlling blood lipid, lowering blood sugar, regulating intestinal canal microbial flora, inhibiting composition of toxic fermentation product, promoting mineral absorption, protecting liver, preventing constipation and treating obesity, and can be used for ischemic arterial embolism.
The red yeast rice is sweet in taste, warm in nature and free of toxicity, belongs to liver, spleen and large intestine channels, and has the effects of promoting blood circulation to remove blood stasis, invigorating spleen to promote digestion, reducing blood fat, reducing blood pressure, reducing cholesterol and triglyceride, enhancing human immunity and the like.
The sunflower disc small molecular peptide has the effects of expanding blood vessels and softening blood vessels, can effectively reduce the cholesterol content in serum, plays a role in purifying blood, and has a good protection effect on cardiovascular and cerebrovascular diseases.
The selenium element in the edible selenium powder has the functions of improving the immunity of human bodies, eliminating free radicals, protecting optic nerves, protecting the liver and the heart and preventing toxic substances from being generated in the human bodies.
Glutathione, which consists of glutamic acid, cysteine and glycine, is present in almost every cell of the body, helps to maintain normal immune system function, and has antioxidant and antidotal effects. Glutathione acts as an important antioxidant and free radical scavenger in the body. It is combined with free radical, heavy metal, etc. to convert harmful matter into harmless matter and eliminate it from body.
Selenium acts in combination with glutathione to eliminate free radicals (meaning substances that are unpaired by electrons and that are detrimental to cell membranes, DNA, proteins and molecules of overall cellular structure and function) and protect the health of the cell. Glutathione itself is easily depleted and therefore needs to be replenished continuously and in a timely manner. Too low a glutathione content in the human body can lead to inflammation, toxicity, etc., and loss of synaptic support components, etc. Severe patients also induce the development of cognitive decline in the brain and senile dementia. Selenium plays a critical role in the remodeling process after glutathione scavenges free radicals.
The invention can be used for treating hypertension, hyperglycemia and hyperlipidemia, has obvious curative effect on non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus, particularly the main formula, adopts the mutual cooperation of the traditional Chinese medicines to tonify qi and yin, purge dryness-heat hyperactivity and improve the immunity of the organism, and leads the traditional Chinese medicines to play the synergistic effects of nourishing yin and tonifying qi, strengthening spleen and tonifying kidney, promoting the production of body fluid to quench thirst, moistening dryness and relieving restlessness so as to achieve the purpose of adjusting the balance of yin and yang of the upper, middle and lower triple energizer of viscera. Restoring the sensitivity of the tissue of the body affected by the inflammation to insulin. Repairing damaged internal organs. After the viscera are well regulated, the carbohydrate absorbed every day can be fully transferred into the cells of the human body and converted into the nutrition and energy of each organ of the human body after being converted into glucose. Glucose can be delivered into cells only after the viscera are conditioned. Diabetes can really improve and recover, and complications can really disappear.
Compared with the prior art, the invention has the advantages that:
the invention mainly adopts a main formula and a correction formula to realize the effective prevention and treatment of three highs by combining Chinese and western medicines, has obvious treatment effect, combines the pathogenesis and pathology of the three highs, can realize the treatment of both principal and secondary aspect of disease, and can be matched with a dietary therapy auxiliary formula and a vitamin auxiliary formula to improve the immunity of human bodies and strengthen the treatment effect.
Detailed Description
The present invention is further described below with reference to specific embodiments, and it should be noted that, without conflict, any combination between the embodiments or technical features described below may form a new embodiment.
Example 1: a compound prescription for treating diabetes and three highs consists of a main prescription and a correction prescription, wherein the main prescription comprises the following raw materials in parts by weight:
120 g of astragalus, 120 g of rhizoma polygonati, 20g of coptis, 60 g of red ginseng, 120 g of radix scrophulariae, 120 g of salvia miltiorrhiza, 120 g of raw Chinese yam, 120 g of raw pollen, 40 g of radix puerariae, 20g of fructus alpiniae oxyphyllae, 10g of semen plantaginis, 20g of rhizoma atractylodis, 20g of rhizoma cimicifugae, 20g of radix bupleuri, 20g of pericarpium citri reticulatae, 20g of poria cocos, 20g of rhizoma atractylodis macrocephalae and 10g of liquorice;
the prescription is prepared from the following raw materials:
earthworm protein, nattokinase, lumbrokinase, hirudin, inulin, red yeast rice, sunflower disc small molecular peptide, edible selenium powder and glutathione.
The food therapy auxiliary formula also comprises a food therapy auxiliary formula and a vitamin auxiliary formula, wherein the food therapy auxiliary formula is prepared from the following raw materials in parts by weight: 100 g of peanut, medlar, red date, gordon euryale seed, ginger and astragalus root respectively;
the vitamin auxiliary formula consists of B vitamins, folic acid, mercurial-preserving silver tablets and dried yeast tablets.
Example 2: a compound prescription for treating diabetes and three highs consists of a main prescription and a correction prescription, wherein the main prescription comprises the following raw materials in parts by weight:
360 g of astragalus, 360 g of rhizoma polygonati, 60 g of coptis, 180 g of red ginseng, 360 g of radix scrophulariae, 360 g of salvia miltiorrhiza, 360 g of raw Chinese yam, 360 g of raw pollen, 120 g of radix puerariae, 60 g of fructus alpiniae oxyphyllae, 30 g of semen plantaginis, 60 g of rhizoma atractylodis, 60 g of rhizoma cimicifugae, 60 g of radix bupleuri, 60 g of pericarpium citri reticulatae, 60 g of poria cocos, 60 g of rhizoma atractylodis macrocephalae and 30 g of liquorice;
the prescription is prepared from the following raw materials:
earthworm protein, nattokinase, lumbrokinase, hirudin, inulin, red yeast rice, sunflower disc small molecular peptide, edible selenium powder and glutathione.
The food therapy auxiliary formula also comprises a food therapy auxiliary formula and a vitamin auxiliary formula, wherein the food therapy auxiliary formula is prepared from the following raw materials in parts by weight: 100 g of peanut, medlar, red date, gordon euryale seed, ginger and astragalus root respectively;
the vitamin auxiliary formula consists of B vitamins, folic acid, mercurial-preserving silver tablets and dried yeast tablets.
The food therapy auxiliary formula of the embodiment 1 and the embodiment 2 has the eating mode that the raw materials are mixed and then are stewed by adopting a pressure cooker, and then the food therapy auxiliary formula is eaten instead of breakfast.
The main formula of the embodiment 1 and the embodiment 2 can be prepared into decoction, powder or capsule for administration.
The components of the vitamin auxiliary formula can be taken according to the conventional dosage.
Example 3: typical cases
Wangzhi, man, 76 years old, Shandong tobacco Tairen, who saw a doctor in 11 months and 01 days in 2020, who had diabetes and hypertension for more than twenty years, took orally hypoglycemic western medicines: xiaotangning, pioglitazone hydrochloride, a blood pressure lowering western medicine metformin and a kidney tonifying and pulse invigorating capsule. Due to high blood pressure and the like, the heart is not good enough, sinus bradycardia and arrhythmia also exist in the neck arterial plaque. The long-term administration of hypotensor can be controlled at 110/65 (after western medicine is taken). There is a smoking and drinking preference.
In the afternoon of 10 months and 1 day in 2020, the patient feels dizzy and falls down dangerously. After the family holds the person, the left leg cannot walk well in the forward walking process, and the person feels like stepping on cotton. The right leg is strong. The patient is sent to the hospital and is taken with western medicines, etc., the current situation is maintained, no improvement is found, and the patient is returned to the home and is in bed for rest.
The tongue coating is observed in 1 st 11 th month in 2020, and is white, thick and greasy, and belongs to phlegm-dampness, yang deficiency and qi deficiency, and the veins in the sublingual Jinjin and Yuye are irritated and become purple. Diagnosing the thrombus and the serious blockage of the artery and the vein in the body. Through comprehensive diagnosis, the disease belongs to the diabetes mellitus of phlegm dampness, qi deficiency, yang deficiency and blood stasis, and the three-high syndrome.
The preparation is used for treatment in embodiment 2 of the invention, a dietotherapy auxiliary formula is used for replacing breakfast in the treatment process, the vitamin auxiliary formula is taken according to the conventional method, the main formula in embodiment 1 is taken, one dose is taken every day, after 7 doses of the main formula are taken, the supplementation is started, a patient takes about 20g of the preparation per day, after ten days, the dose is reduced to about 10g per day, and the preparation is taken under the tongue once. The main formula is continuously taken while the correction is taken.
After twenty days of treatment, the patient obviously changes that the defecation quantity is obviously reduced, the fury veins at the sublingual Jinjin jade liquid are disappeared, the color of the veins becomes light, the head is not dizzy before twenty days, and the left leg is forceful and does not float.
3, 7 and 5, 26 in 2021, the body of the old improves, symptoms disappear completely, the body recovers to a normal state, and the blood pressure and the blood sugar are only slightly higher than normal values but within a reasonable range.
The invention and its embodiments have been described above, without this being limitative. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (4)

1. The compound prescription for treating diabetes and three highs is characterized by comprising a main prescription and a supplement prescription, wherein the main prescription is prepared from the following raw materials:
radix astragali, rhizoma Polygonati, Coptidis rhizoma, Ginseng radix Rubri, radix scrophulariae, Saviae Miltiorrhizae radix, rhizoma Dioscoreae, pollen, radix Puerariae, fructus Alpinae Oxyphyllae, semen plantaginis, rhizoma Atractylodis, cimicifugae rhizoma, bupleuri radix, pericarpium Citri Tangerinae, Poria, Atractylodis rhizoma, and Glycyrrhrizae radix;
the prescription is prepared from the following raw materials:
earthworm protein, nattokinase, lumbrokinase, hirudin, inulin, red yeast rice, sunflower disc small molecular peptide, edible selenium powder and glutathione.
2. The compound prescription for treating diabetes and hypertension, hyperglycemia and hyperlipidemia according to claim 1, wherein the dosage of each raw material of the main prescription is as follows:
360 g of astragalus mongholicus, 360 g of rhizoma polygonati, 20-60 g of coptis chinensis, 60-180 g of red ginseng, 360 g of radix scrophulariae, 120 g of salvia miltiorrhiza, 360 g of raw Chinese yam, 120 g of raw pollen, 40-120 g of radix puerariae, 20-60 g of sharpleaf galangal fruit, 10-30 g of plantain seed, 20-60 g of rhizoma atractylodis, 20-60 g of rhizoma cimicifugae, 20-60 g of radix bupleuri, 20-60 g of pericarpium citri reticulatae, 20-60 g of poria cocos, 20-60 g of rhizoma atractylodis macrocephalae and 10-30 g of liquorice.
3. The compound recipe for treating diabetes and hypertension, according to claim 1 or 2, characterized by further comprising a dietetic assistant recipe, wherein the dietetic assistant recipe is prepared from the following raw materials by weight: 100 g of peanut, medlar, red date, gordon euryale seed, ginger and astragalus root respectively.
4. The compound recipe for treating diabetes and hypertension, hyperlipidemia and hyperglycemia as claimed in any one of claims 1 to 3, further comprising a vitamin assistant recipe, wherein the vitamin assistant recipe consists of B vitamins, folic acid, LIANGCHUNYIN tablet, and dried yeast tablet.
CN202110763131.5A 2021-07-06 2021-07-06 Compound prescription for treating diabetes and three highs Withdrawn CN113368225A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110763131.5A CN113368225A (en) 2021-07-06 2021-07-06 Compound prescription for treating diabetes and three highs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110763131.5A CN113368225A (en) 2021-07-06 2021-07-06 Compound prescription for treating diabetes and three highs

Publications (1)

Publication Number Publication Date
CN113368225A true CN113368225A (en) 2021-09-10

Family

ID=77581123

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110763131.5A Withdrawn CN113368225A (en) 2021-07-06 2021-07-06 Compound prescription for treating diabetes and three highs

Country Status (1)

Country Link
CN (1) CN113368225A (en)

Similar Documents

Publication Publication Date Title
CN103520577A (en) Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation
CN103495040A (en) Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof
CN110584132A (en) Special medical nutritional formula food for kidney diseases and preparation method thereof
CN111135235A (en) A composition for preventing and relieving acute alcoholism or alcoholic intoxication
CN115645491A (en) Traditional Chinese medicine composition for tonifying spleen and lung and preparation method thereof
CN108478714A (en) A kind of paediatrics self-closing disease rehabilitation auxiliary Chinese medicine composition
CN107823293A (en) Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof
CN113368225A (en) Compound prescription for treating diabetes and three highs
CN115089661A (en) Application of ginseng composition for assisting in regulating endocrine metabolism and resisting and preventing cancer
CN1213760C (en) Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis
CN107260978B (en) Traditional Chinese medicine composition for treating hypertension and preparation method and application thereof
CN102145059B (en) Chinese patent medicament for treating intractable hypertension
CN110882362A (en) Traditional Chinese medicine food therapy product for conditioning diabetes and preparation method thereof
CN101810751B (en) Chinese medicinal preparation for treating pediatric mesenteric lymph node inflammation
CN118044611A (en) Lung-clearing and lung-protecting nutrition product
CN101019988B (en) Diabetes treating Chinese medicine
CN118356466A (en) A Chinese medicinal capsule for treating diabetes
CN118105442A (en) Pharmaceutical composition for treating high fever unconsciousness and inducing resuscitation
CN104225009A (en) Traditional Chinese medicine composition for treating diarrhea
CN118078920A (en) Preparation for promoting blood circulation, removing blood stasis, dissolving thrombus and reducing three highs and preparation method thereof
CN115814036A (en) Medicinal composition for invigorating spleen, calming liver, promoting digestion and stimulating appetite, preparation and application thereof
CN1151310A (en) Oral liquid for treatment of heart disease and its prepn. method
CN116549520A (en) Qi-blood tonifying, lung heat clearing and cough relieving traditional Chinese medicine formula, traditional Chinese medicine liquid and traditional Chinese medicine preparation
US20230233636A1 (en) Traditional chinese medicine composition and product for improving sleep by balancing yin and yang, method for making the same and use thereof
CN112451612A (en) High-efficiency anti-alcohol traditional Chinese medicine composition and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20210910

WW01 Invention patent application withdrawn after publication